Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

KMV Narayana Rao appointed as Vice President - ARD at NATCO Research Centre

Ruchika Sharma15 Jun 2024 11:56 AM IST

Hyderabad: Through a recent BSE filing, Natco Pharma has informed that K.M.V. Narayana Rao has been appointed as Vice President - ARD at NATCO...

Bayer gets Breakthrough Therapy designation in China for lung cancer drug BAY 2927088

Ruchika Sharma15 Jun 2024 10:00 AM IST

Berlin: Bayer has announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) in China has...

Pfizer Duchenne gene therapy fails to meet primary end point in Phase 3 CIFFREO trial

Ruchika Sharma14 Jun 2024 5:23 PM IST

New York: Pfizer Inc. has announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating...

Health Ministry Proposes Notification-Based Approval for Pharma Export BE Studies Instead of Central Licensing Authority Nod

Zydus Lifesciences bags USFDA tentative nod for Azilsartan Medoxomil and Chlorthalidone Tablets for hypertension

Ruchika Sharma14 Jun 2024 4:02 PM IST

Ahmedabad: Zydus Lifesciences Limited has announced that the Company has received tentative approval from the United States Food and Drug...

Lupin unveils Glucagon for Injection for severe hypoglycemia in patients with diabetes mellitus in US

Lupin Nagpur Injectable facility concludes USFDA inspection with zero 483 observations

Ruchika Sharma14 Jun 2024 12:33 PM IST

Mumbai: Global pharma major Lupin Limited today announced that the United States Food and Drug Administration (U.S. FDA) has completed an...

USFDA approves Tonix Pharma Tonmya for fibromyalgia in adults

AstraZeneca Farxiga gets USFDA nod for paediatric type 2 diabetes

Ruchika Sharma14 Jun 2024 11:30 AM IST

Cambridge: AstraZeneca has announced that the US Food and Drug Administration (FDA) has approved Farxiga (dapagliflozin) for the improvement of...

Dr Reddys Labs API Mirfield facility gets 7 USFDA observations

Dr Reddy's Labs to commercialize Ingenus Pharma cancer injection Cyclophosphamide in US

Ruchika Sharma13 Jun 2024 4:40 PM IST

Hyderabad: Dr Reddy's Laboratories, Inc., a step down wholly owned subsidiary of the Company (referred to hereinafter as "Dr. Reddy's USA"), and...

Biocon appoints Mukesh Kamath as Interim CFO, Key Managerial Personnel

Ruchika Sharma13 Jun 2024 4:09 PM IST

Bangalore: Biocon has announced the appointment of Mukesh Kamath, Head - Business Finance R&D, as the Interim Chief Financial Officer and Key...

USFDA concludes inspection at Zydus Lifesciences SEZ II, Ahmedabad plant

Torrent Pharma gets 5 USFDA observations for Indrad facility

Ruchika Sharma13 Jun 2024 12:09 PM IST

Ahmedabad: Through a recent BSE filing, Torrent Pharma has informed that the US Food and Drug Administration (USFDA) has issued Form 483...

Pune Pharmacist Loses Rs 95 Lakh in Medical Store Deal

Lupin collaborates with Fuji Pharma arm for marketing birth control pill Nextstellis in Vietnam, Philippines

Ruchika Sharma12 Jun 2024 5:43 PM IST

Mumbai: Global pharma major Lupin Limited today announced that it has signed a license and supply agreement with OLIC (Thailand) Limited, a...

Cohance Lifesciences announces USD 10 mn investment in cGMP Bioconjugation Suite at NJ Bio

Kotak Alt infuses Rs 1445 crore for acquisition of API business of Viatris by Matrix Pharma

Ruchika Sharma12 Jun 2024 3:44 PM IST

Mumbai: Kotak Alternate Asset Managers Limited, has announced an investment of Rs 1445 crore for acquisition of API business of Viatris by...

Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancer

Focused on second- and third-generation opportunities in cardiometabolic drugs market: Merck

Ruchika Sharma12 Jun 2024 1:46 PM IST

Merck emphasized its focus on second- and third-generation opportunities within the cardiometabolic drugs market, including weight-loss therapies, the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok